Cui Zhou

638 total citations
20 papers, 326 citations indexed

About

Cui Zhou is a scholar working on Epidemiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Cui Zhou has authored 20 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Cui Zhou's work include Liver Disease Diagnosis and Treatment (8 papers), Neuroscience and Neuropharmacology Research (4 papers) and Liver physiology and pathology (2 papers). Cui Zhou is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Neuroscience and Neuropharmacology Research (4 papers) and Liver physiology and pathology (2 papers). Cui Zhou collaborates with scholars based in China and United States. Cui Zhou's co-authors include Hongmin Yu, Dong Han, Chong Li, Yuecheng Guo, Mingyi Xu, Zhenghong Li, Lungen Lu, Xiaoyan Zhou, Xin Luo and Shengzheng Luo and has published in prestigious journals such as Brain Research, Frontiers in Microbiology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Cui Zhou

19 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cui Zhou China 11 146 97 52 48 47 20 326
Yoichiro Asai Japan 8 140 1.0× 50 0.5× 60 1.2× 19 0.4× 29 0.6× 15 336
Hae Yong Pae United States 7 182 1.2× 83 0.9× 20 0.4× 30 0.6× 72 1.5× 10 435
Xuezhi Cui United States 15 279 1.9× 108 1.1× 12 0.2× 45 0.9× 84 1.8× 27 610
Shan Sun China 11 199 1.4× 117 1.2× 32 0.6× 24 0.5× 16 0.3× 22 382
Mingkai Li China 9 93 0.6× 75 0.8× 40 0.8× 24 0.5× 47 1.0× 38 294
Aditi Swarup United States 8 216 1.5× 50 0.5× 33 0.6× 26 0.5× 20 0.4× 13 311
Shin‐Ichi Ueno Japan 11 153 1.0× 100 1.0× 14 0.3× 55 1.1× 50 1.1× 33 486
Wisuit Pradidarcheep Thailand 10 213 1.5× 61 0.6× 15 0.3× 73 1.5× 37 0.8× 27 456

Countries citing papers authored by Cui Zhou

Since Specialization
Citations

This map shows the geographic impact of Cui Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui Zhou more than expected).

Fields of papers citing papers by Cui Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cui Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui Zhou. The network helps show where Cui Zhou may publish in the future.

Co-authorship network of co-authors of Cui Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Cui Zhou. A scholar is included among the top collaborators of Cui Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cui Zhou. Cui Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Panjie, Changrui Qian, Qingxia Fu, et al.. (2025). Antimicrobial and Anti-Biofilm Activity of Dichlorophen-Functionalized Gold Nanoparticles Against Carbapenem-Resistant Enterobacteriaceae. International Journal of Nanomedicine. Volume 20. 10255–10277.
2.
Zhou, Huijing, Xin Du, Yue Wang, et al.. (2024). Antimicrobial peptide A20L: in vitro and in vivo antibacterial and antibiofilm activity against carbapenem-resistant Klebsiella pneumoniae. Microbiology Spectrum. 12(8). e0397923–e0397923. 4 indexed citations
3.
Shen, Bo, Tianyi Gu, Cui Zhou, et al.. (2023). Escherichia coli Promotes Endothelial to Mesenchymal Transformation of Liver Sinusoidal Endothelial Cells and Exacerbates Nonalcoholic Fatty Liver Disease Via Its Flagellin. Cellular and Molecular Gastroenterology and Hepatology. 16(6). 857–879. 27 indexed citations
4.
Zhou, Cui, Bo Shen, Yuecheng Guo, et al.. (2023). FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(7). 166810–166810. 18 indexed citations
5.
Shen, Bo, Cui Zhou, Xin Luo, et al.. (2023). Expansion of macrophage and liver sinusoidal endothelial cell subpopulations during non-alcoholic steatohepatitis progression. iScience. 26(5). 106572–106572. 11 indexed citations
6.
Liu, Ying, Xiao‐Hua Li, Cui Zhou, et al.. (2023). Dissection of Cellular Communication between Human Primary Osteoblasts and Bone Marrow Mesenchymal Stem Cells in Osteoarthritis at Single-Cell Resolution. International Journal of Stem Cells. 16(3). 342–355. 8 indexed citations
7.
Xu, Chunquan, Tao Chen, Siqin Zhang, et al.. (2022). In vitro activity of imipenem-relebactam alone and in combination with fosfomycin against carbapenem-resistant gram-negative pathogens. Diagnostic Microbiology and Infectious Disease. 103(3). 115712–115712. 5 indexed citations
8.
Guo, Yuecheng, Xianjun Xu, Hui Dong, et al.. (2022). Loss of YB-1 alleviates liver fibrosis by suppressing epithelial-mesenchymal transition in hepatic progenitor cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(11). 166510–166510. 4 indexed citations
9.
Shi, Yishi, Xiaodong Zhang, Zhuocheng Yao, et al.. (2022). Synergistic effect of the novel β-lactamase inhibitor BLI-489 combined with imipenem or meropenem against diverse carbapenemase-producing carbapenem-resistant Enterobacterales. Journal of Antimicrobial Chemotherapy. 77(5). 1301–1305. 5 indexed citations
10.
Shen, Bo, Cui Zhou, Tianyi Gu, et al.. (2022). Kuhuang alleviates liver fibrosis by modulating gut microbiota-mediated hepatic IFN signaling and bile acid synthesis. Frontiers in Pharmacology. 13. 8 indexed citations
11.
Shen, Bo, Yuecheng Guo, Tianyi Gu, et al.. (2021). Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice With Non-alcoholic Steatohepatitis. Frontiers in Microbiology. 12. 756299–756299. 28 indexed citations
12.
Luo, Xin, Shengzheng Luo, Cui Zhou, et al.. (2021). Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease. World Journal of Gastroenterology. 27(14). 1419–1434. 52 indexed citations
13.
Qiu, Xiang, Ying Liu, Hui Shen, et al.. (2021). Single-cell RNA sequencing of human femoral head in vivo. Aging. 13(11). 15595–15619. 32 indexed citations
14.
Ye, Jianzhong, Qīng Wáng, Yating Li, et al.. (2020). Integrated Multichip Analysis Identifies Potential Key Genes in the Pathogenesis of Nonalcoholic Steatohepatitis. Frontiers in Endocrinology. 11. 601745–601745. 10 indexed citations
15.
Wang, Mei, Dashi Qi, Cui Zhou, et al.. (2016). Ischemic preconditioning protects the brain against injury via inhibiting CaMKII–nNOS signaling pathway. Brain Research. 1634. 140–149. 15 indexed citations
16.
Zhou, Cui, et al.. (2014). Influence of Microwave and Ultrasound on Sludge Dewaterability. Advanced materials research. 955-959. 2074–2079. 9 indexed citations
17.
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoichiro Asai Breakdown of academic impact, for papers by Hae Yong Pae Breakdown of academic impact, for papers by Xuezhi Cui Breakdown of academic impact, for papers by Shan Sun Breakdown of academic impact, for papers by Mingkai Li Breakdown of academic impact, for papers by Aditi Swarup Breakdown of academic impact, for papers by Shin‐Ichi Ueno Breakdown of academic impact, for papers by Wisuit Pradidarcheep
Rankless by CCL
2026